找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Hepatitis B Virus and Liver Disease; Jia-Horng Kao,Ding-Shinn Chen Book 20181st edition Springer Nature Singapore Pte Ltd. 2018 hepatocell

[復制鏈接]
樓主: 挑染
31#
發(fā)表于 2025-3-26 23:05:37 | 只看該作者
32#
發(fā)表于 2025-3-27 04:19:03 | 只看該作者
33#
發(fā)表于 2025-3-27 08:04:38 | 只看該作者
Immunopathogenesis of Hepatitis B Virus (HBV) Infection, in chronic HBV-infected individuals. Therefore, it is important to fully understand the course of immune pathogenesis and to find efficient immunotherapy plus nucleoside analogue(NUC) or IFN-α treatment to completely eliminate or functionally cure HBV infection. In this chapter, we summarizes the c
34#
發(fā)表于 2025-3-27 10:50:50 | 只看該作者
Epidemiology and Natural History of Chronic Hepatitis B Virus Infection,onal vaccination programs has significantly decreased prevalence in multiple countries in both Asia and Africa. The initiation of antiviral therapy in pregnant mothers with detectable virus can also reduce the risk of perinatal HBV transmission when combined with vaccination and, where available, HB
35#
發(fā)表于 2025-3-27 14:07:17 | 只看該作者
Hepatitis B Vaccines,ood vaccination, as children infected with HBV at birth or early childhood are at greatest risk for developing chronic HBV infection and HBV-related liver disease in later life. Globally, universal hepatitis B vaccination is recommended for all infants beginning preferably within 24 hours of birth,
36#
發(fā)表于 2025-3-27 21:23:06 | 只看該作者
Viral Factors Affecting Disease Progression,-HBc antibody, have been also associated with the long-term prognosis of CHB patients. All these qualitative and quantitative viral factors contribute to the disease progression. With the advance of technology, more new viral biomarkers may emerge in the future. Combination of all current and new vi
37#
發(fā)表于 2025-3-28 01:52:39 | 只看該作者
38#
發(fā)表于 2025-3-28 03:49:41 | 只看該作者
39#
發(fā)表于 2025-3-28 09:06:51 | 只看該作者
40#
發(fā)表于 2025-3-28 14:20:41 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 23:38
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
绥滨县| 玛纳斯县| 新绛县| 增城市| 齐河县| 平泉县| 东海县| 庆元县| 响水县| 扎兰屯市| 鄂伦春自治旗| 和田县| 盱眙县| 大荔县| 大理市| 宣汉县| 普宁市| 龙口市| 宝山区| 石柱| 海口市| 宜都市| 全椒县| 嘉黎县| 清远市| 静海县| 景东| 阳谷县| 大姚县| 明星| 乐平市| 基隆市| 利川市| 花莲市| 兴山县| 淅川县| 新疆| 武宁县| 绥江县| 潮安县| 罗平县|